DAVID HALL
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
DIRECTOR
DIRECTOR
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
KRISTIAN EVERARD, SIMON FINCH, BRIAN GENTILE, VICTORIA GLAYSHER, DAVID IAN HALL, PETER MCCORD, KENNETH PAQVALEN, MATTHEW SCULLION, DHARMESH THAKKER, DHARMESH DINESH THAKKER, EDWARD THOMPSON, EDWARD GEORGE THOMPSON, RYTIS VITKAUSKAS, ANDREW VITUS, ANDREW LENNART VITUS, ANDY VITUS, ANGELA WARNER, ANDREAS WEISKAM, ANDREAS MARKUS WEISKAM, ANDREAS WELSKAM
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER TECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2024-11-26
D
OTHER TECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2023-03-14
D
OTHER TECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2023-02-01
D
OTHER TECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2023-01-17
D
OTHER TECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2022-12-30
D
OTHER TECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2022-05-04
D
OTHER TECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2021-12-17
D/A
OTHER TECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2021-06-02
D
OTHER TECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2021-06-02
D
OTHER TECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2021-05-17
D
OTHER TECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2021-02-08

